| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |